Works matching AU Li, Ziming


Results: 134
    1
    2
    3
    4
    5

    Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadj uvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Populations: A Multi-Center Retrospective Cohort Study.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 5, p. 395, doi. 10.1016/j.cllc.2024.03.008
    By:
    • Hanbo Pan;
    • Hang Chen;
    • Weicheng Kong;
    • Junwei Ning;
    • 4# Zhen Ge;
    • Yu Tian;
    • Ningyuan Zou;
    • Hongda Zhu;
    • 1 Jiaqi Zhang;
    • Yixing Tao;
    • Zenan Gu;
    • Min Zheng;
    • 4 Guomo Ruan Long Jiang;
    • Ziming Li;
    • Jia Huang;
    • Chengwei Zhou;
    • Guodong Xu;
    • Qingquan Luol
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    A Portable Plasma Sterilizer.

    Published in:
    Plasma Chemistry & Plasma Processing, 2017, v. 37, n. 1, p. 77, doi. 10.1007/s11090-016-9751-0
    By:
    • Du, ChangMing;
    • Shang, Chao;
    • Wang, Ting;
    • Li, ZiMing;
    • Yang, Xin;
    • Chen, HaiTian;
    • Liu, Ya;
    • Wang, Kui
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432).

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02060-3
    By:
    • Ai, Xinghao;
    • Jia, Bo;
    • He, Zhiyi;
    • Zhang, Junping;
    • Zhuo, Minglei;
    • Zhao, Jun;
    • Wang, Zhe;
    • Zhang, Jiexia;
    • Fan, Zaiwen;
    • Zhang, Xiaotong;
    • Li, Chong;
    • Jin, Feng;
    • Li, Ziming;
    • Ma, Xia;
    • Tang, Hao;
    • Yan, Xiang;
    • Li, Wei;
    • Xiong, Yuanyuan;
    • Yin, Huan;
    • Chen, Rongrong
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01283-7
    By:
    • Zhou, Zhen;
    • Ding, Zhengping;
    • Yuan, Jie;
    • Shen, Shengping;
    • Jian, Hong;
    • Tan, Qiang;
    • Yang, Yunhai;
    • Chen, Zhiwei;
    • Luo, Qingquan;
    • Cheng, Xinghua;
    • Yu, Yongfeng;
    • Niu, Xiaomin;
    • Qian, Liqiang;
    • Chen, Xiaoke;
    • Gu, Linping;
    • Liu, Ruijun;
    • Ma, Shenglin;
    • Huang, Jia;
    • Chen, Tianxiang;
    • Li, Ziming
    Publication type:
    Article